FDAnews Drug Daily Bulletin

PAR'S PROFIT JUMPS 212%

May 2, 2006
A A

Par Pharmaceutical on Monday announced income growth of 212 percent and sales growth of 78 percent, exceeding analysts' expectations and underlining the strength of the generic drug industry.
Red Herring